fusidic acid has been researched along with nitazoxanide in 2 studies
Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (nitazoxanide) | Trials (nitazoxanide) | Recent Studies (post-2010) (nitazoxanide) |
---|---|---|---|---|---|
1,742 | 117 | 344 | 573 | 85 | 352 |
Protein | Taxonomy | fusidic acid (IC50) | nitazoxanide (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 8.22 | |
Signal transducer and activator of transcription 3 | Homo sapiens (human) | 9.89 | |
Anoctamin-1 | Homo sapiens (human) | 0.424 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Johnson, S; Venugopal, AA | 1 |
1 review(s) available for fusidic acid and nitazoxanide
Article | Year |
---|---|
Current state of Clostridium difficile treatment options.
Topics: Anti-Bacterial Agents; Bacitracin; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Fusidic Acid; Humans; Metronidazole; Nitro Compounds; Secondary Prevention; Severity of Illness Index; Teicoplanin; Thiazoles; Treatment Outcome; Vancomycin | 2012 |
1 other study(ies) available for fusidic acid and nitazoxanide
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |